Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 30:5:e3395.
doi: 10.7717/peerj.3395. eCollection 2017.

Clinical impact of human papillomavirus in laryngeal squamous cell carcinoma: a retrospective study

Wei-Chih Chen  1   2 , Hui-Ching Chuang  1   2 , Yu-Tsai Lin  1   2 , Chao-Cheng Huang  2   3 , Chih-Yen Chien  1   2
Affiliations

Clinical impact of human papillomavirus in laryngeal squamous cell carcinoma: a retrospective study

Wei-Chih Chen et al. PeerJ. .

Abstract

Objectives: The purpose of this study is to determine the prevalence and clinical impact of human papillomavirus (HPV) related laryngeal squamous cell carcinoma (LSCC).

Methods: A total of 106 LSCC patients who underwent primary surgical resection with or without adjuvant radiotherapy/chemoradiotherapy were enrolled retrospectively. Tumors collected from paraffin-embedded samples were used for HPV detection by polymerase chain reaction and in situ hybridization technique. Clinicopathological parameters were recorded for analysis.

Results: The prevalence of HPV in patients with LSCC was 13.2% in our series and 12 out of 14 (85.7%) HPV-positive tumors were HPV-16. The patients with HPV-positive tumors were older (p = 0.042), less local/regional recurrence (p = 0.037) and non-smoker (p = 0.068). There was no significant difference in the 5-year overall survival (OS) (p = 0.8056) between HPV-positive and -negative tumors. The patients with HPV-positive tumors had a better 5-year disease-specific survival (DSS) (100% vs. 84.8%, p = 0.1485), although the difference did not reach statistical significance. However, the local/regional control rate was significantly better in HPV-positive tumors than in HPV-negative tumors (100% vs. 75%, p = 0.0494).

Conclusions: A low prevalence of HPV infection in our series suggests that HPV is not a major cause of LSCC. However, a 100% local/regional control rate and DSS were observed in HPV-positive tumors. This finding suggests a different tumor behavior between HPV-positive and HPV-negative LSCC. Further research with a larger sample size is necessary to confirm our observations.

Keywords: HPV; Laryngeal cancer; Prevalence; Recurrence; Survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no competing interests.

Figures

Figure 1
Figure 1. The distributions of different HPV types.
The distributions of (A) various HPV types in laryngeal cancer and (B) HPV at different laryngeal subsites.
Figure 2
Figure 2. Clinical outcome in HPV-positive and HPV-negative tumors.
The effect of HPV status on (A) overall survival, (B) disease-specific survival, and (C) local/regional control rates.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. The New England Journal of Medicine. 2010;363:24–35. doi: 10.1056/NEJMoa0912217. - DOI - PMC - PubMed
    1. Armas GL, Su CY, Huang CC, Fang FM, Chen CM, Chien CY. The impact of virus in N3 node dissection for head and neck cancer. European Archives of Otorhinolaryngology. 2008;265:1379–1384. doi: 10.1007/s00405-008-0670-4. - DOI - PubMed
    1. Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ, Snijders PJ, Yarbrough WG, Slebos RJ. Human papillomavirus in early laryngeal carcinoma. The Laryngoscope. 2009;119:1531–1537. doi: 10.1002/lary.20509. - DOI - PubMed
    1. Bonagura VR, Hatam LJ, Rosenthal DW, De Voti JA, Lam F, Steinberg BM, Abramson AL. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118:455–470. doi: 10.1111/j.1600-0463.2010.02617.x. - DOI - PMC - PubMed
    1. Castellsagué X, Alemany L, Quer M, Halec G, Quiros B, Tous S, Clavero O, Alos L, Biegner T, Szafarowski T, Alejo M, Holzinger D, Cadena E, Claros E, Hall G, Laco J, Poljak M, Benevolo M, Kasamatsu E, Mehanna H, Ndiaye C, Guimerà N, Lloveras B, León X, Ruiz-Cabezas JC, Alvarado-Cabrero I, Kang CS, Oh JK, Garcia-Rojo M, Iljazovic E, Ajayi OF, Duarte F, Nessa A, Tinoco L, Duran-Padilla MA, Pirog EC, Viarheichyk H, Morales H, Costes V, Félix A, Germar MJ, Mena M, Ruacan A, Jain A, Mehrotra R, Goodman MT, Lombardi LE, Ferrera A, Malami S, Albanesi EI, Dabed P, Molina C, López-Revilla R, Mandys V, González ME, Velasco J, Bravo IG, Quint W, Pawlita M, Muñoz N, De Sanjosé S, Xavier Bosch F. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. Journal of the National Cancer Institute. 2016;108:djv403. doi: 10.1093/jnci/djv403. - DOI - PubMed

LinkOut - more resources